Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Breast Cancer Research and Treatment
Catherine A McCartyRegina G Ziegler

Abstract

We tested the hypothesis that genes involved in the alcohol oxidation pathway modify the association between alcohol intake and breast cancer. Subjects were women aged 55-74 at baseline from the screening arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Incident breast cancers were identified through annual health surveys. Controls were frequency matched to cases by age and year of entry into the trial. A self-administered food frequency questionnaire queried frequency and usual serving size of beer, wine or wine coolers, and liquor. Three SNPs in genes in the alcohol metabolism pathway were genotyped: alcohol dehydrogenase 2, alcohol dehydrogenase 3, and CYP2E1. The study included 1,041 incident breast cancer cases and 1,070 controls. In comparison to non-drinkers, the intake of any alcohol significantly increased the risk of breast cancer, and this risk increased with each category of daily alcohol intake (OR 2.01, 95% CI 1.14, 3.53) for women who drank three or more standard drinks per day. Stratification by genotype revealed significant gene/environment interactions. For the ADH1B gene, there were statistically significant associations between all levels of alcohol intake and risk of breast ...Continue Reading

References

Jul 1, 1995·Journal of the American Dietetic Association·A F SubarL Kruse
Dec 1, 1994·American Journal of Epidemiology·P C NascaB B Metzger
Jan 23, 1999·Free Radical Biology & Medicine·R M WrightJ E Repine
Mar 31, 1999·British Journal of Cancer·S M EngerL Bernstein
Jul 27, 1999·The Journal of Steroid Biochemistry and Molecular Biology·E S Ginsburg
Feb 24, 2001·Controlled Clinical Trials·P C ProrokUNKNOWN Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Feb 24, 2001·American Journal of Epidemiology·A F SubarUNKNOWN Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Investigators
Nov 22, 2001·JAMA : the Journal of the American Medical Association·K W Singletary, S M Gapstur
Jan 5, 2002·Breast Cancer Research and Treatment·M IscanH Raunio
Feb 16, 2002·Journal of the American Dietetic Association·Frances E ThompsonRegina G Ziegler
Dec 14, 2005·Carcinogenesis·Mary Beth TerryRegina M Santella
Apr 8, 2006·The American Journal of Clinical Nutrition·Rachael Z Stolzenberg-SolomonRegina G Ziegler
Feb 14, 2007·Alcoholism, Clinical and Experimental Research·Kala VisvanathanKathy J Helzlsouer
Dec 17, 2009·The American Journal of Clinical Nutrition·Brietta M OaksRachael Z Stolzenberg-Solomon
Dec 29, 2010·Cancer Management and Research·Alain Monnier

❮ Previous
Next ❯

Citations

Aug 2, 2012·Nutrients·Sara ArranzRamón Estruch
Nov 23, 2013·Current Breast Cancer Reports·Jasmine A McDonaldMary Beth Terry
Sep 10, 2014·International Journal of Food Sciences and Nutrition·Niki MouroutiDemosthenes B Panagiotakos
Aug 9, 2012·Mechanisms of Ageing and Development·Jack W KentSarah Williams-Blangero
Mar 19, 2014·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Hassan R Dhaini, Loulou Kobeissi
Nov 18, 2014·World Journal of Gastroenterology : WJG·Yan SunChang-Qing Zheng
Jan 27, 2021·Genes & Nutrition·Simona CostanzoSalvatore Panico

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.